Phenylephrine HCl SR Pellets Manufacturer & Supplier in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Phenylephrine HCl SR Pellets – Pharmaceutical-Grade Sustained-Release Pellets

Phenylephrine HCl SR Pellets are multiparticulate pharmaceutical pellets containing Phenylephrine Hydrochloride and designed for sustained-release formulation development. The SR pellet format can provide a platform for incorporating a controlled release profile into suitable oral dosage forms.

Phenylephrine Hydrochloride has the molecular formula C₉H₁₃NO₂·HCl, molecular weight 203.67 g/mol, and CAS Number 61-76-7. The current USP-NF monograph specifies Phenylephrine Hydrochloride at 98.0%–102.0%, calculated on the dried basis.

Commercial pharmaceutical-pellet listings specifically identify Phenylephrine Hydrochloride SR Pellets and report a 10% w/w commercial presentation. This is a market reference and should not be entered as the SDP product strength unless confirmed by SDP's own specification.

Key Features

  • Phenylephrine Hydrochloride-based SR pellets
  • Pharmaceutical Grade
  • Sustained-release multiparticulate format
  • Suitable for oral dosage-form development
  • Suitable for capsule-filling applications
  • Controlled active-ingredient release profile
  • Free-flowing pellet format
  • Pellet loading and release characteristics can be product-specific
  • Suitable for bulk pharmaceutical formulation requirements

Applications

Phenylephrine HCl SR Pellets can be used for:

  • Sustained-release capsule formulations
  • Multiparticulate oral dosage forms
  • Capsule filling
  • Modified-release formulation development
  • Pharmaceutical formulation development
  • Combination multiparticulate formulations where technically compatible
  • Bulk formulation and manufacturing requirements

Manufacturing & Processing

SR pellets can be manufactured using suitable pelletization, layering and functional-coating technologies. The final release profile depends on factors such as active-ingredient loading, pellet size, coating composition, coating weight gain and process parameters.

For this reason, assay, pellet size, moisture, coating weight gain and dissolution/release limits should be taken from the validated SDP product specification rather than inferred from the Phenylephrine HCl API monograph.

Quality & Testing

Phenylephrine HCl SR Pellets may be evaluated for:

  • Identification
  • Assay by HPLC
  • Related substances
  • Loss on drying / moisture
  • Residue on ignition where applicable
  • Particle-size distribution
  • Pellet morphology
  • Mechanical strength / friability
  • Dissolution and sustained-release profile
  • Coating uniformity where applicable

The USP API monograph specifies 98.0%–102.0% assay on the dried basis. It should not automatically be used as the finished-pellet assay limit.

Detailed Specifications

Parameter Specification
Appearance white to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) 98.0% – 102.0%
Loss on Drying NMT 0.5%
Residue on Ignition NMT 0.1%
Heavy Metals NMT 10 ppm
Individual Impurity NMT 0.5%
Total Impurities NMT 1.0%
Water Content NMT 0.5%
Get Bulk Quote via WhatsApp